Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription
- 29 July 2010
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 323 (2), 268-276
- https://doi.org/10.1016/j.mce.2010.03.013
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- miR-21 as a key regulator of oncogenic processesBiochemical Society Transactions, 2009
- Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cellsNucleic Acids Research, 2009
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast CancerJournal of Biological Chemistry, 2008
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1Journal of Biological Chemistry, 2008
- Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer CellsToxicological Sciences, 2008
- Variant estrogen receptor–c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activationProceedings of the National Academy of Sciences of the United States of America, 2007
- A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cellsOncogene, 2007
- A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancerGenes & Development, 2006
- A variant of estrogen receptor-α, hER-α36: Transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signalingProceedings of the National Academy of Sciences of the United States of America, 2006
- Antiestrogen resistance in breast cancer and the role of estrogen receptor signalingOncogene, 2003